Nelson Peltz May or May Not Have a Board Seat at P&G, but His Influence Is Already Evident
Yesterday, Procter & Gamble (NYSE: PG) revealed that activist investor Nelson Peltz has jumped ahead in a proxy vote recount to determine whether his firm Trian Partners can obtain a seat on P&G's board. Shareholders may remember that P&G rushed to declare victory in mid-October based on initial estimates, before independent proxy-vote tabulator IVS Associates had processed all the votes.
In what is decidedly not the final round of this proxy war -- in which the two sides have collectively spent over $125 million -- Peltz now leads the vote count by a margin which, if it gets any slimmer, will soon be reported in scientific notation: 0.0016%.
Image source: Getty Images.
Source: Fool.com
Procter & Gamble Co. Stock
€150.68
-0.490%
The stock is an absolute favorite of our community with 23 Buy predictions and no Sell predictions.
With a target price of 159 € there is a slightly positive potential of 5.52% for Procter & Gamble Co. compared to the current price of 150.68 €.
